Attached files
| file | filename |
|---|---|
| EX-99.1 - EXHIBIT 99.1 - CurAegis Technologies, Inc. | ex99-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
Date of Report (Date of Earliest Event Reported): |
August 11, 2016 |
CurAegis Technologies, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
|
New York |
000-24455 |
16-1509512 |
|
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
|
1999 Mt. Read Blvd, Bldg. 3, Rochester, New York |
14615 | |
|
(Address of principal executive offices) |
(Zip Code) |
|
Registrant’s telephone number, including area code: |
585-254-1100 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01 |
Regulation FD Disclosure |
On August 11, 2016, CurAegis Technologies, Inc. issued a press release announcing the Beta Trial Program is planned to begin early in the fourth quarter of 2016. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
|
Item 9.01 |
Financial Statements and Exhibits |
|
99.1 |
August 11, 2016 press release providing an update of the Company’s Beta trial program planned for the fourth quarter of 2016. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
CurAegis Technologies, Inc. |
| |
|
|
|
|
|
|
|
|
|
|
|
August 11, 2016 |
By: |
/s/ Kathleen A. Browne |
|
|
|
|
Kathleen A. Browne |
|
|
|
|
Chief Financial Officer |
|
3